This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Jul 1;73(1):e59-e61.

doi: 10.1093/cid/ciaa533.

Antimicrobial Stewardship: A Potentially Important Benefit of a Group A Streptococcus Vaccine in Areas With Low Rates of Acute Rheumatic Fever

Robert R Tanz¹, Stanford T Shulman²

Affiliations

Affiliations

¹ Division of Academic General Pediatrics & Primary Care, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
² Division of Infectious Diseases, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

PMID: 32374821
DOI: 10.1093/cid/ciaa533

Editorial

Antimicrobial Stewardship: A Potentially Important Benefit of a Group A Streptococcus Vaccine in Areas With Low Rates of Acute Rheumatic Fever

Robert R Tanz et al. Clin Infect Dis. 2021.

. 2021 Jul 1;73(1):e59-e61.

doi: 10.1093/cid/ciaa533.

Authors

Robert R Tanz¹, Stanford T Shulman²

Affiliations

¹ Division of Academic General Pediatrics & Primary Care, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
² Division of Infectious Diseases, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

PMID: 32374821
DOI: 10.1093/cid/ciaa533

No abstract available

Keywords: Group A streptococcus; Streptococcus pyogenes; antimicrobial stewardship; vaccine.

PubMed Disclaimer

Comment on

Incidence of Pharyngitis, Sinusitis, Acute Otitis Media, and Outpatient Antibiotic Prescribing Preventable by Vaccination Against Group A Streptococcus in the United States.
Lewnard JA, King LM, Fleming-Dutra KE, Link-Gelles R, Van Beneden CA. Lewnard JA, et al. Clin Infect Dis. 2021 Jul 1;73(1):e47-e58. doi: 10.1093/cid/ciaa529. Clin Infect Dis. 2021. PMID: 32374829

Similar articles

[Is an antistreptococcal vaccine available at last?].
Reyes López PA. Reyes López PA. Arch Inst Cardiol Mex. 1996 Sep-Oct;66(5):387-9. Arch Inst Cardiol Mex. 1996. PMID: 9103163 Spanish. No abstract available.
The future streptococcal M. vaccine against rheumatic fever.
Imran M, Jan A. Imran M, et al. J Pak Med Assoc. 1988 Jul;38(7):176-7. J Pak Med Assoc. 1988. PMID: 3149682 No abstract available.
Streptococcal vaccines and global strategies for prevention of rheumatic fever.
Stollerman GH. Stollerman GH. Am J Med. 1980 May;68(5):636-8. doi: 10.1016/0002-9343(80)90241-7. Am J Med. 1980. PMID: 6990756 No abstract available.
A vaccine against Streptococcus pyogenes: the potential to prevent rheumatic fever and rheumatic heart disease.
Guilherme L, Ferreira FM, Köhler KF, Postol E, Kalil J. Guilherme L, et al. Am J Cardiovasc Drugs. 2013 Feb;13(1):1-4. doi: 10.1007/s40256-013-0005-8. Am J Cardiovasc Drugs. 2013. PMID: 23355360 Review.
[Rheumatic fever--rheumatic carditis].
Kawakita S, Iwamoto H. Kawakita S, et al. Nihon Rinsho. 1973 Dec;31(12):3402-8. Nihon Rinsho. 1973. PMID: 4598900 Review. Japanese. No abstract available.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information